Neonatal abstinence syndrome: treatment and pediatric outcomes
- PMID: 23314720
- PMCID: PMC3589586
- DOI: 10.1097/GRF.0b013e31827feea4
Neonatal abstinence syndrome: treatment and pediatric outcomes
Abstract
Recent rise in rates of opiate replacement therapy among pregnant women have resulted in increasing number of infants requiring treatment for neonatal abstinence syndrome (NAS). Short-term and long-term developmental outcomes associated with prenatal opiate exposure are discussed, including symptoms and severity of NAS, and early cognitive and motor delays. Maternal and infant risk factors are discussed, and include patterns of maternal substance use during pregnancy, genetic risk, polysubstance exposure pharmacological treatment for NAS and breastfeeding. The importance of characterizing corollary environmental risk factors is also considered.
Similar articles
-
Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.Am J Perinatol. 2017 Jul;34(9):918-921. doi: 10.1055/s-0037-1600917. Epub 2017 Mar 20. Am J Perinatol. 2017. PMID: 28320034
-
Could prenatal food insecurity influence neonatal abstinence syndrome severity?Addiction. 2019 Feb;114(2):337-343. doi: 10.1111/add.14458. Epub 2018 Nov 13. Addiction. 2019. PMID: 30422365
-
The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.J Matern Fetal Neonatal Med. 2016 Mar;29(5):783-8. doi: 10.3109/14767058.2015.1018168. Epub 2015 Mar 23. J Matern Fetal Neonatal Med. 2016. PMID: 25758627 Free PMC article. Clinical Trial.
-
Neonatal abstinence syndrome.Curr Opin Pediatr. 2012 Apr;24(2):252-8. doi: 10.1097/MOP.0b013e32834fdc3a. Curr Opin Pediatr. 2012. PMID: 22227786 Review.
-
Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome.Neonatal Netw. 2016;35(5):277-86. doi: 10.1891/0730-0832.35.5.277. Neonatal Netw. 2016. PMID: 27636691 Review.
Cited by
-
Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.Neurotoxicol Teratol. 2021 Jul-Aug;86:106975. doi: 10.1016/j.ntt.2021.106975. Epub 2021 Mar 23. Neurotoxicol Teratol. 2021. PMID: 33766722 Free PMC article.
-
Effects of Pharmacologic Treatment for Neonatal Abstinence Syndrome on DNA Methylation and Neurobehavior: A Prospective Cohort Study.J Pediatr. 2022 Apr;243:21-26. doi: 10.1016/j.jpeds.2021.12.057. Epub 2021 Dec 28. J Pediatr. 2022. PMID: 34971656 Free PMC article.
-
Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study.Can J Public Health. 2023 Apr;114(2):277-286. doi: 10.17269/s41997-022-00726-5. Epub 2022 Dec 8. Can J Public Health. 2023. PMID: 36482143 Free PMC article.
-
Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.Harm Reduct J. 2021 Aug 4;18(1):83. doi: 10.1186/s12954-021-00532-1. Harm Reduct J. 2021. PMID: 34348734 Free PMC article.
-
Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome.Front Pediatr. 2020 Aug 27;8:462. doi: 10.3389/fped.2020.00462. eCollection 2020. Front Pediatr. 2020. PMID: 32974241 Free PMC article.
References
-
- NSDUH. National Survey on Drug Use and Health: National Findings. 2008
-
- TEDS; DHHS, OSA. Treatment Episode Data Set (TEDS) 2007.
-
- Oei J, Lui K. Management of the newborn infant affected by maternal opiates and other drugs of dependency. Journal of Paediatrics and Child Health. 2007;43(1–2):9–18. - PubMed
-
- McCarthy JJ. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus? J Matern-Fetal Neo M. 2012;25(2):109–112. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical